Clinical Trials
37 trialsNCT05852990 2026-04-09
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
NCT06027242 2025-12-23
Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
National Taiwan University Hospital
Phase NA Recruiting
NCT07287592 2025-12-17
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University
Phase 3 Not yet recruiting
NCT04634539 2025-08-06
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
Cedars-Sinai Medical Center
Phase 1 Completed
NCT01607879 2023-09-22
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Medical College of Wisconsin
Phase 2 Completed
NCT05856188 2023-05-12
Efficacy of Glutamine in Management of Radiation Mucositis
Ain Shams University
Phase NA Unknown
NCT01952847 2022-06-15
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT05054517 2021-09-23
Oral Glutamine and Thoracic/Upper Aerodigestive Tumors Radiation Toxicity
National and Kapodistrian University of Athens
Completed
NCT04388371 2021-08-11
Glutamine PET Imaging in LAM
Vanderbilt University Medical Center
Phase 1 Completed
NCT04710290 2021-01-25
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
E-DA Hospital
Phase 2/3 Unknown
NCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
NCT01704664 2020-03-17
Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients
Medical University of Bialystok
Phase NA Unknown
NCT01983969 2020-01-27
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02589145 2019-12-13
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT01783522 2019-10-22
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT00772824 2018-07-17
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Banaras Hindu University
Phase 4 Completed
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT01032512 2018-02-19
Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology
University of Chile
Phase 3 Withdrawn
NCT01552291 2018-02-13
Glutaminprojec
Insel Gruppe AG, University Hospital Bern
Phase 4 Completed
NCT02215083 2017-07-12
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Phase 1 Withdrawn
NCT00217724 2017-05-09
Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT02961816 2017-04-21
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT03015077 2017-01-10
Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT00003170 2016-07-14
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02701673 2016-05-04
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT00255229 2016-02-25
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
AHS Cancer Control Alberta
Phase 2 Completed
NCT01157039 2016-02-24
A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin
AHS Cancer Control Alberta
Phase 2 Withdrawn
NCT00006994 2015-11-18
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 3 Terminated
NCT02282839 2015-11-04
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Taichung Veterans General Hospital
Phase 3 Unknown
NCT02114502 2014-07-11
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02024191 2013-12-31
GELUPO
Ankara Education and Research Hospital
Phase 3 Unknown
NCT00334984 2013-07-11
Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
Children's Oncology Group
Phase NA Withdrawn
NCT01087658 2013-06-21
GLUTOX
Sanofi
Phase 3 Completed
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed
NCT00003898 2011-03-01
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
Roswell Park Cancer Institute
Phase 2 Completed